Retraction Note: Sepsis-induced elevation in plasma serotonin facilitates endothelial hyperpermeability (Scientific Reports, (2016), 6, 1, (22747), 10.1038/srep22747);Sepsis-induced elevation in plasma serotonin facilitates endothelial hyperpermeability

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Li, Yicong ^a   Hadden, Coedy ^a   Cooper, Anthonya ^a   Ahmed, Asli ^a   Wu, Hong ^a   Lupashin, Vladimir V ^a   Mayeux, Philip R ^a   Kilic, Fusun ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SEROTONIN AGONIST;

ANIMAL; BLOOD; C57BL MOUSE; CAPILLARY PERMEABILITY; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; ENDOTHELIUM CELL; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLASMA; SEPSIS;

ANIMALS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; MALE; MICE, INBRED C57BL; PLASMA; SEPSIS; SEROTONIN; SEROTONIN RECEPTOR AGONISTS;

EID: 84960533356     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-019-50843-4     Document Type: Erratum

References (48)

1. Schortgen F., & Asfar P. Update in sepsis, and acute kidney injury 2014. Am. J. Respir. Crit. Care Med. 191, 1226-1231 (2015).
2. Zarbock A., Gomez H., & Kellum J. A. Sepsis-induced acute kidney injury revisited: pathophysiology, prevention, and future therapies. Curr. Opin. Crit. Care. 20, 588-595 (2014).
3. de Stoppelaar S. F., et al. Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice. Blood. 124, 3781-3790 (2014).
4. Vincent J. L., Yagushi A., & Pradier O. Platelet function in sepsis. Crit. Care Med. 30, S313-S317 (2002).
5. Ho-Tin-Noe B., Demers M., & Wagner D. D. How platelets safeguard vascular integrity. J. Thromb. Haemost. 9, Suppl 1: 56-65 (2011).
6. Cloutier N., et al. Platelets can enhance vascular permeability. Blood. 120, 1334-1343 (2012).
7. Corken A., Russell S., Dent J., Post S. R., & Ware J. Platelet glycoprotein Ib-IX as a regulator of systemic inflammation. Arterioscler. Thromb. Vasc. Biol. 34, 996-1001 (2014).
8. Schouten M., Wiersinga W. J., Levi M., & van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J. Leukoc. Biol. 83, 536-545 (2008).
9. Sonda S., et al. Serotonin regulates amylase secretion, and acinar cell damage during murine pancreatitis. Gut. 62, 890-898 (2013).
10. Aszodi A., et al. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP-, and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J. 18, 37-48 (1999).
11. Ohtani A., Kozono N., Senzaki K., & Shiga T. Serotonin 2A receptor regulates microtubule assembly, and induces dynamics of dendritic growth cones in rat cortical neurons in vitro. Neurosci. Res. 81-82, 11-20 (2014).
12. Majno G., & Palade G. E. Studies on inflammation. 1. The effect of histamine, and serotonin on vascular permeability: an electron microscopic study. J. Biophys. Biochem. Cytol. 11, 571-605 (1961).
13. Majno G., & Palade G. E. I. Schoefl, Studies on inflammation. II. The site of action of histamine, and serotonin along the vascular tree: a topographic study. J. Biophys. Biochem. Cytol. 11, 607-626 (1961).
14. Tang D. D., Bai Y., & Gunst S. J. Silencing of p21-Activated kinase attenuates vimentin phosphorylation on Ser-56, and reorientation of the vimentin network during stimulation of smooth muscle cells by 5-hydroxytryptamine. Biochem. J. 388, 773-783 (2005).
15. Li Q. F., et al. Critical role of vimentin phosphorylation at Ser-56 by p21-Activated kinase in vimentin cytoskeleton signaling. J. Biol. Chem. 281, 34716-34724 (2006).
16. Ahmed B. A., et al. The cellular distribution of serotonin transporter is impeded on serotonin-Altered vimentin network. PLoS One. 4, e4730 (2009).
17. Mercado C. P., & Kilic F. Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels. Molecular Interventions. 10, 231-241 (2010).
18. Pathak E., MacMillan-Crow L. A., & Mayeux P. R. Role of mitochondrial oxidants in an in vitro model of sepsis-induced renal injury. J. Pharmacol. Exp. Ther. 340, 192-201 (2012).
19. Pathak E., & Mayeux P. R. In vitro model of sepsis-induced renal epithelial reactive nitrogen species generation. Toxicol. Sci. 115, 475-481 (2010).
20. Brenner B., et al. Plasma serotonin levels, and the platelet serotonin transporter. J. Neurochem. 102, 206-215 (2007).
21. Robinson N. A., & Eckert Identification of transglutaminase-reactive residues in S100A11. J. Biol. Chem. 273, 2721-2728 (1998).
22. Ziu E., et al. Downregulation of the serotonin transporter in hyperreactive platelets counteracts the pro-Thrombotic effect of serotonin. J. Mol. Cell Cardiol. 52, 1112-1121 (2012).
23. Walther A., Petri E., Peter C., Czabanka M., & Martin E. Selective serotonin-receptor antagonism, and microcirculatory alterations during experimental endotoxemia. J. Surg. Res. 143, 216-223 (2007).
24. Ahmed B. A., et al. Serotonin transamidates Rab4, and facilitates its binding to the C terminus of serotonin transporter. J. Biol. Chem. 283, 9388-9398 (2008).
25. Walther D. J., et al. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell. 115, 851-862, 2003
26. Wang Z., et al. Development of oxidative stress in the peritubular capillary microenvironment mediates sepsis-induced renal microcirculatory failure, and acute kidney injury. Am. J. Pathol. 180, 505-516 (2012).
27. De Backer D., et al. Microcirculatory alterations in patients with severe sepsis: impact of time of assessment, and relationship with outcome. Crit. Care Med. 41, 791-799 (2013).
28. De Backer D., Orbegozo-Cortes D., Donadello K., & Vincent J. L. Pathophysiology of microcirculatory dysfunction, and the pathogenesis of septic shock. Virulence. 5, 73-79 (2014).
29. Spanos A., Jhanji S., Vivian-Smith A., Harris T., & Pearse R. M. Early microvascular changes in sepsis, and severe sepsis. Shock. 33, 387-391 (2010).
30. Holthoff J. H., Wang Z., Patil N. K., Gokden N., & Mayeux P. R. Rolipram improves renal perfusion, and function during sepsis in the mouse. J. Pharmacol. Exp. Ther. 347, 357-364 (2013).
31. Wang Z., Sims C. R., Patil N. K., Gokden N., & Mayeux P. R. Pharmacologic targeting of sphingosine-1-phosphate receptor 1 improves the renal microcirculation during sepsis in the mouse. J. Pharmacol. Exp. Ther. 352, 61-66 (2015).
32. Dejana E. Endothelial cell-cell junctions: happy together. Nat. Rev. Mol. Cell Biol. 5, 261-270 (2004).
33. Mehta D., & Malik A. B. Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86, 279-367 (2006).
34. Hawiger J., Hawiger A., Steckley S., Timmons S., & Cheng C. Membrane changes in human platelets induced by lipopolysaccharide endotoxin. Br. J. Haematol. 35, 285-299 (1977).
35. Abbott N. J. Inflammatory mediators, and modulation of blood-brain barrier permeability. Cell. Mol. Neurobiol. 20, 131-147 (2000).
36. Stewart P. A. Endothelial vesicles in the blood-brain barrier: are they related to permeability?. Cell. Mol. Neurobiol. 20, 149-163 (2000).
37. Bokoch G. M. Biology of the p21-Activated kinases. Annu. Rev. Biochem. 72, 743-781 (2003).
38. Eriksson J. E., et al. Introducing intermediate filaments: from discovery to disease. J. Clin. Invest. 119, 1763-1771 (2009).
39. Shasby D. M., Ries D. R., Shasby S. S., & Winter M. C. Histamine stimulates phosphorylation of adherens junction proteins, and alters their link to vimentin. Am. J. Physiol. Lung. Cell Mol. Physiol. 282, L1330-1338 (2002).
40. Liu T., et al. Modulating endothelial barrier function by targeting vimentin phosphorylation. J Cell Physiol. 229, 1484-1493 (2014).
41. Mendez M. G., Kojima S., & Goldman R. D. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J. 24, 1838-1851 (2010).
42. Helfand B. T., et al. Vimentin organization modulates the formation of lamellipodia. Mol Biol Cell. 22, 1274-1289 (2011).
43. Akinosoglou K., & Alexopoulos D. Use of antiplatelet agents in sepsis: A glimpse into the future. Throm. Res. 133, 131-138 (2014).
44. Duerschmied D., et al. Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. Blood. 121, 1008-1015 (2013).
45. Cines D. B., et al. Endothelial cells in physiology, and in the pathophysiology of vascular disorders. Blood. 15, 3527-3561 (1998).
46. Mercado C. P., et al. A serotonin-induced N-glycan switch regulates platelet aggregation. Sci. Rep. 3, 2795 (2013).
47. Moitra J., Sammani S., & Garcia J. G. Re-evaluation of Evans Blue dye as a marker of albumin clearance in murine models of acute lung injury. Trans Res. 150, 253-265 (2007).
48. Pokrovskaya I. D., et al. Conserved oligomeric Golgi complex specifically regulates the maintenance of Golgi glycosylation machinery. Glycobiology. 21, 1554-1569 (2011).